Glaucoma alters the circadian timing system

PLoS ONE

Volumn 3, Issue 12, 2008, Pages

  Drouyer, Elise ^a,b   Dkhissi Benyahya, Ouria ^a,b   Chiquet, Christophe ^a,d   WoldeMussie, Elizabeth ^e   Ruiz, Guadalupe ^f   Wheeler, Larry A ^f   Denis, Philippe ^a,g   Cooper, Howard M ^a,b,c  

^a STEM CELL AND BRAIN RESEARCH INSTITUTE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c CNRS   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e PFIZER INC   (United States)

^f ALLERGAN INC   (United States)

^g EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOPSIN; MESSENGER RNA; BIOLOGICAL MARKER; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; OPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; GLAUCOMA; INTRAOCULAR HYPERTENSION; LIGHT DARK CYCLE; LIGHT EXPOSURE; LOCOMOTION; MALE; MAMMAL; NERVE ENDING; NONHUMAN; PATHOLOGICAL ANATOMY; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RETINA CONE; RETINA GANGLION CELL; RETINA ROD; SUPRACHIASMATIC NUCLEUS; VISUAL STIMULATION; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; GENICULATE BODY; INTRAOCULAR PRESSURE; LASER COAGULATION; LIGHT; METABOLISM; MOTOR ACTIVITY; NERVE FIBER; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; SUPERIOR COLLICULUS; TIME; VISUAL SYSTEM; WISTAR RAT;

MAMMALIA; RATTUS; RODENTIA;

ANIMALS; AXONS; BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; GENE EXPRESSION REGULATION; GENICULATE BODIES; GLAUCOMA; INTRAOCULAR PRESSURE; LASER COAGULATION; LIGHT; MALE; MOTOR ACTIVITY; OPSINS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; RETINAL GANGLION CELLS; RNA, MESSENGER; SUPERIOR COLLICULI; SUPRACHIASMATIC NUCLEUS; TIME FACTORS; VISUAL PATHWAYS;

EID: 57849098900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003931     Document Type: Article

References (69)

1. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3): 262-267.
2. Leske MC (1983) The epidemiology of open-angle glaucoma: a review. Am J Epidemiol 118(2): 166-191.
3. Quigley HA (1993) Open-angle glaucoma. N Engl J Med 328: 1097-1106.
4. Quigley HA (1999) Neuronal death in glaucoma. Prog Retin Eye Res 18: 39-57.
5. Van Buskirk EM, Cioffi GA (1992) Glaucomatous optic neuropathy. Am J Ophthalmol 113(4): 447-452.
6. Friedman DS, Wilson MR, Liebmann JM, Fechtner RD, Weinreb RN (2004) An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol 38(3): S19-31.
7. Boland MV, Quigley HA (2007) Risk factors and open-angle glaucoma: classification and application. J Glaucoma 16(4): 406-418.
8. Harwerth RS, Carter-Dawson L, Smith EL III, Barnes G, Holt WF, et al. (2004) Neural losses correlated with visual losses in clinical perimetry. Invest Ophthalmol Vis Sci 45: 3152-3160.
9. Harwerth RS, Quigley HA (2006) Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol 124(6): 853-859.
10. Quigley HA, Dunkelberger GR, Green WR (1988) Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 95(3): 357-363.
11. Quigley HA, Sanchez RM, Dunkelberger GR, L'Hernault NL, Baginski TA (1987) Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci 28(6): 913-920.
12. Glovinsky Y, Quigley HA, Dunkelberger GR (1991) Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci 32(3): 484-491.
13. Glovinsky Y, Quigley HA, Pease ME (1993) Foveal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci 34(2): 395-400.
14. Jakobs TC, Libby RT, Ben Y, John SW, Masland RH (2005) Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol 171(2): 313-325.
15. Berson DM, Dunn FA, Takao M (2002) Phototransduction by retinal ganglion cells that set the circadian clock. Science 295: 1070-1073.
16. Hattar S, Liao HW, Takao M, Berson DM, Yau KW (2002) Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 295(5557): 1065-1070.
17. Warren EJ, Allen CN, Brown RL, Robinson DW (2003) Intrinsic light responses of retinal ganglion cells projecting to the circadian system. Eur J Neurosci 17(9): 1727-1735.
18. Dacey DM, Liao HW, Peterson BB, Robinson FR, Smith VC, et al. (2005) Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature 433: 749-754.
19. Gooley JJ, Lu J, Fischer D, Saper CB (2003) A broad role for melanopsin in nonvisual photoreception. J Neurosci 23(18): 7093-7106.
20. Panda S, Sato TK, Castrucci AM, Rollag MD, DeGrip WJ, et al. (2002) Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science 298(5601): 2213-2216.
21. Hattar S, Lucas RJ, Mrosovsky N, Thompson S, Douglas RH, et al. (2003) Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature 424: 76-81.
22. Mrosovsky N, Hattar S (2003) Impaired masking responses to light in melanopsin-knockout mice. Chronobiol Int 20(6): 989-99.
23. Cajochen C, Munch M, Kobialka S, Krauchi K, Steiner R, et al. (2005) High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab 90(3): 1311-1316.
24. Hattar S, Kumar M, Park A, Tong P, Tung J, et al. (2006) Central projections of melanopsin-expressing retinal ganglion cells in the mouse. J Comp Neurol 497: 326-349.
25. Morin LP, Blanchard JH, Provencio I (2003) Retinal ganglion cell projections to the hamster suprachiasmatic nucleus, intergeniculate leaflet, and visual midbrain: bifurcation and melanopsin immunoreactivity. J Comp Neurol 465(3): 401-416.
26. Panda S, Provencio I, Tu DC, Pires SS, Rollag MD, et al. (2003) Melanopsin is required for non-image-forming photic responses in blind mice. Science 301: 525-527.
27. Lucas RJ, Hattar S, Takao M, Berson DM, Foster RG, et al. (2003)) Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice. Science 299: 245-247.
28. Mure LS, Rieux C, Hattar S, Cooper HM (2007) Melanopsin-dependent non-visual responses by light: evidence for photopigment bistability in vivo. J Biol Rhythms 22(5): 411-424.
29. Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, et al. (1997) Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab 82(11): 3763-3770.
30. Skene DJ, Lockley SW, James K, Arendt J (1999) Correlation between urinary cortisol and 6-sulphatoxymelatonin rhythms in field studies of blind subjects. Clin Endocrinol 50(6): 715-719.
31. Tabandeh H, Lockley SW, Buttery R, Skene DJ, Defrance R, et al. (1998) Disturbance of sleep in blindness. Am J Ophthalmol 126(5): 707-712.
32. Li RS, Chen BY, Tay DK, Chan HH, Pu ML, et al. (2006) Melanopsin-expressing retinal ganglion cells are more injury-resistant in a chronic ocular hypertension model. Invest Ophthalmol Vis Sci 47(7): 2951-2958.
33. WoldeMussie E, Ruiz G, Wijono M, Wheeler LA (2001) Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci 42(12): 2849-2855.
34. Rieux C, Carney R, Lupi D, Dkhissi-Benyahya O, Janssen K, et al. (2002) Evaluation of different methods of quantification of immunohistochemical label of the immediate early gene cfos: Analysis of immunohistochemical label of Fos protein in the SCN. J Biol Rhythms 17: 121-136.
35. Cooper HM, Herbin M, Nevo E (1993) Mosaic evolution: ocular regression conceals adaptive progression of the visual system in a blind subterranean mammal. Nature 361: 156-159.
36. Dkhissi-Benyhaya O, Sicard B, Cooper HM (2000) Effects of irradiance and stimulus duration on early gene expression (Fos) in the suprachiasmatic nucleus: temporal summation and reciprocity. J Neurosci 20(20): 7790-7797.
37. Provencio I, Cooper HM, Foster RG (1998) Retinal projections in mice with inherited retinal degeneration: Implications for circadian photoentrainment. J Comp Neurol 395(4): 417-39.
38. Dkhissi-Benyahya O, Gronfier C, De Vanssay W, Flamant F, Cooper HM (2007) Modelling the role of mid-wavelength cones in circadian responses to light. Neuron 53: 677-687.
39. Siminoff R, Schwassmann HO, Kruger L (1966) An electrophysiological study of the visual projection to the superior colliculus of the rat. J Comp Neurol 127(4): 435-444.
40. Lund RD, Lund JS, Wise RP (1974) The organization of the retinal projection to the dorsal lateral geniculate nucleus in pigmented and albino rats. J Comp Neurol 158(4): 383-403.
41. Sawada A, Neufeld AH (1999) Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp Eye Res 69(5): 525-531.
42. Morgan JE, Uchida H, Caprioli J (2000) Retinal ganglion cell death in experimental glaucoma. Br J Ophthalmol 84(3): 303-310.
43. Hare WA, Ton H, Ruiz G, Feldmann B, Wijono M, et al. (2001) Characterization of retinal injury using ERG measures obtained with both conventional and multifocal methods in chronic ocular hypertensive primates. Invest Ophthalmol Vis Sci 42(1): 127-136.
44. Diaz F, Villena A, Moreno M, Vidal L, Parrado C, et al. (2005) Effects of a non-selective beta-blocker on adult rat anterograde axonal transport and retinal ganglion layer after increased intraocular pressure. Histol Histopathol 20(4): 1077-1084.
45. Dandona I, Hendrickson A, Quigley HA (1991) Selective effects of experimental glaucoma on axonal transport by retinal ganglion cells to the dorsal lateral geniculate nucleus. Invest Ophthalmol Vis Sci 32: 1593-1599.
46. Filippopoulos T, Danias J, Chen B, Podos SM, Mittag TW (2006) Topographic and morphologic analyses of retinal ganglion cell loss in old DBA/2NNia mice. Invest Ophthalmol Vis Sci 47(5): 1968-1974.
47. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, et al. (2002) The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6): 714-720.
48. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, et al. (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6): 701-713.
49. Palmberg P (2002) Answers from the ocular hypertension treatment study. Arch Ophthalmol 120(6): 829-830.
50. Hannibal J, Hindersson P, Knudsen SM, Georg B, Fahrenkrug J (2002) Melanopsin is expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract. J Neurosci 22(1): RC191 (1-7).
51. Son YJ, Park JW, Lee BJ (2007) TTF-1 expression in PACAP-expressing retinal ganglion cells. Mol Cells 23(2): 215-219.
52. Kendell KR, Quigley HA, Kerrigan LA, Pease ME, Quigley EN (1995) Primary open-angle glaucoma is not associated with photoreceptor loss. Invest Ophthalmol Vis Sci 36(1): 200-205.
53. Wygnanski T, Desatnik H, Quigley HA, Glovinsky Y (1995) Comparison of ganglion cell loss and cone loss in experimental glaucoma. Am J Ophthalmol 120(2): 184-189.
54. Nork TM, Ver Hoeve JN, Poulsen GL, Nickells RW, Davis MD, et al. (2000) Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch Ophthalmol 118(2): 235-245.
55. Raz D, Seeliger MW, Geva AB, Percicot CL, Lambrou GN, et al. (2002) The effect of contrast and luminance on mferg responses in a monkey model of glaucoma. Invest Ophthalmol Vis Sci 43(6): 2027-2035.
56. Ver-Hoeve JA, Kim C, Heatley G, Kaufman P, Kiland J, et al. (2001) Delay of an early multifocal erg wave feature in experimental glaucoma. Invest Ophthalmol Vis Sci 42: S148.
57. Pelzel HR, Schlamp CL, Poulsen GL, Ver Hoeve JA, Nork TM, et al. (2006) Decrease of cone opsin mRNA in experimental ocular hypertension. Mol Vis 12: 1272-1282.
58. Barnard AR, Hattar S, Hankins MW, Lucas RJ (2006) Melanopsin regulates visual processing in the mouse retina. Curr Biol 16(4): 389-395.
59. Storch KF, Paz C, Signorovitch J, Raviola E, Pawlyk B, et al. (2007) Intrinsic circadian clock of the Mammalian retina: importance for retinal processing of visual information. Cell 130(4): 730-741.
60. Mrosovsky N (2003) Contribution of classic photoreceptors to entrainment. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 189: 69-73.
61. Wright KP Jr, Hughes RJ, Kronauer RE, Dijk DJ, Czeisler CA (2001) Intrinsic near-24-h pacemaker period determines limits of circadian entrainment to a weak synchronizer in humans. Proc Natl Acad Sci U S A 98(24): 14027-32.
62. Goz D, Studholme K, Lappi DA, Rollag MD, Provencio I, et al. (2008) Targeted Destruction of Photosensitive Retinal Ganglion Cells with a Saporin Conjugate Alters the Effects of Light on Mouse Circadian Rhythms. PLoS ONE 3(9): e3153.
63. Kaback MB, Podos SM, Harbin TS Jr, Mandell A, Becker B (1976) The effects of dipivalyl epinephrine on the eye. Am J Ophthalmol 81(6): 768-772.
64. Kohn AN, Moss AP, Podos SM (1979) Relative afferent pupillary defects in glaucoma without characteristic field loss. Arch Ophthalmol 97(2): 294-296.
65. Prywes AS (1976) Unilateral afferent pupillary defects in asymmetric glaucoma. Arch Ophthalmol 94(8): 1286-1288.
66. Onen SH, Mouriaux F, Berramdane L, Dascotte JC, Kulik JF, et al. (2000) High prevalence of sleep-disordered breathing in patients with primary open-angle glaucoma. Acta Ophthalmol Scand 78(6): 638-641.
67. Gherghel D, Hosking SL, Orgul S (2004) Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 49(5): 491-508.
68. Chiquet C, Gronfier G, Rieux C, Hut RA, Claustrat B, et al. (2004) Reduced Sensitivity To Light Suppression Of Nocturnal Plasma Melatonin In Glaucoma Patients. Invest Ophthalmol Vis Sci 45(Suppl. 2): U425 (4339).
69. Chiquet C, Drouyer E, Woldemussie E, Ruiz G, Wheeler L, et al. (2006) Consequences of glaucoma on circadian and central visual systems. J Fr Ophtalmol 29(7): 847-851.